לטרוזול טבע ®

Riik: Iisrael

keel: heebrea

Allikas: Ministry of Health

Toimeaine:

LETROZOLE 2.5 MG

Saadav alates:

TEVA PHARMACEUTICAL INDUST.LTD

ATC kood:

L02BG04

Ravimvorm:

TABLETS

Manustamisviis:

PER OS

Valmistatud:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Terapeutiline rühm:

LETROZOLE

Näidustused:

Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Loa andmise kuupäev:

2010-01-01